Advertisement

Allgemeine Pharmakologie

  • E. Oberdisse
Part of the Springer-Lehrbuch book series (SLB)

Zusammenfassung

Wirkstoffe sind chemische Elemente oder chemische Verbindungen, die im Organismus oder auf seiner Oberfläche eine Änderung des Ausgangszustandes des biologischen Systems hervorrufen. Der Begriff des Wirkstoffs wird wertneutral gebraucht und beinhaltet nicht die Frage nach der Nützlichkeit bzw. Schädlichkeit für den menschlichen oder tierischen Organismus.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ariëns EJ, Mutschier E, Simonis AM (1978) Allgemeine Toxikologie. Thieme, Stuttgart New YorkGoogle Scholar
  2. Bacq ZM (ed) (1971) Fundamentals of biochemical pharmacology. Pergamon Press, OxfordGoogle Scholar
  3. Berner B, John VA (1994) Pharmacokinetic characterisation of transdermal delivery systems. Clin Pharmacokinet 26:121–134PubMedCrossRefGoogle Scholar
  4. Berridge MJ (1993) Inositol trisphosphate and calcium signalling. Nature 361:315–325Google Scholar
  5. Brady-Kalnay SM, Tonks NK (1994) Protein tyrosine phosphatases: From structure to function. Trends Cell Biol 4:73–76PubMedCrossRefGoogle Scholar
  6. Brodie BB, Gillette JR (eds) (1971) Concepts in biochemical pharmacology. In: Handbook of Experimental Pharmacology, vol 28/1 and 28/2. Springer, Berlin Heidelberg New YorkGoogle Scholar
  7. Clapham DE (1994) Direct G protein activation of ion channels? Annu Rev Neurosci 17:441–464PubMedCrossRefGoogle Scholar
  8. Coon MJ, Ding X, Pernecky SJ, Vaz ADN (1992) Cytochrome P450: Progress and predictions. FASEB J 6:669–673PubMedGoogle Scholar
  9. Cooper JR, Bloom FE, Roth RH (1991) The biochemical basis of neuropharmacology. Oxford Univ Press, New York OxfordGoogle Scholar
  10. DeLeve LD, Kaplowitz N (1991) Glutathione metabolism and its role in hepatotoxicity. Pharmacol Ther 52:287–305PubMedCrossRefGoogle Scholar
  11. Derendorf H, Garrett ER (1987) Pharmakokinetik, Einführung in die Theorie und Relevanz für die Arzneimitteltherapie. Wiss Verlagsges, StuttgartGoogle Scholar
  12. Drews J (1979) Grundlagen der Chemotherapie. Springer, Wien New YorkCrossRefGoogle Scholar
  13. Eling TE, Curtis JF (1992) Xenobiotic metabolism by prostaglandin H synthase. Pharmacol Ther 53:261–273PubMedCrossRefGoogle Scholar
  14. Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240:889–894PubMedCrossRefGoogle Scholar
  15. Exton JH (1994) Phosphoinositide phospholipases and G proteins in hormone action. Annu Rev Physiol 56:349–369PubMedCrossRefGoogle Scholar
  16. Fantl WJ, Johnson DE, Williams LT (1993) Signalling by receptor tyrosine kinases. Annu Rev Biochem 62:453–481PubMedCrossRefGoogle Scholar
  17. Ferris CD, Snyder SH (1992) Inositol 1,4,5-trisphosphate-activated calcium channels. Annu Rev Physiol 54:469–488PubMedCrossRefGoogle Scholar
  18. Foxwell BMJ, Barrett K, Feldmann M (1992) Cytokine receptors: Structure and signal transduction. Clin Exp Immunol 90:161–169PubMedCrossRefGoogle Scholar
  19. Francis SH, Corbin JD (1994) Structure and function of cyclic nucleotide-dependent protein kinases. Annu Rev Physiol 56:237–272PubMedCrossRefGoogle Scholar
  20. Gasic GP, Hollmann M (1992) Molecular neurobiology of glutamate receptors. Annu Rev Physiol 54:507–536PubMedCrossRefGoogle Scholar
  21. Gillette JR, Mitchell JR (eds) (1975) Concepts in biochemical pharmacology. In: Handbook of Experimental Pharmacology, vol 28/3. Springer, Berlin Heidelberg New YorkGoogle Scholar
  22. Gladtke E, Hattingberg HM v (1977) Pharmakokinetik, 2. Aufl. Springer, Berlin Heidelberg New YorkGoogle Scholar
  23. Gonic L, Wheelis M (1989) Genetik in Cartoons. Parey, Berlin HamburgGoogle Scholar
  24. Gonzalez FJ (1992) Human cytochromes P450: problems and prospects. Trends Pharmacol Sci 13:346–352PubMedCrossRefGoogle Scholar
  25. Graber R, Sumida C, Nunez EA (1994) Fatty acids and cell transduction. J Lipid Med Cell Sign 9:91–116Google Scholar
  26. Guengerich FP (1992) Human cytochrome P-450 enzymes. Life Sci 50:1471–1478PubMedCrossRefGoogle Scholar
  27. Gumbleton M, Sneader W (1994) Pharmacokinetic considerations in rational drug design. Clin Pharmacokinet 26:161–168PubMedCrossRefGoogle Scholar
  28. Hall JM, Caulfield MP, Watson SP, Guard S (1993) Receptor subtypes or species homologues: Relevance to drug discovery. Trends Pharmacol Sci 14:376–383PubMedCrossRefGoogle Scholar
  29. Hankinson O (1995) The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 35:307–340PubMedCrossRefGoogle Scholar
  30. Harnack GA v, Janssen F (1994) Pädiatrische Dosistabellen, 11. Aufl. Wiss Verlagsges, StuttgartGoogle Scholar
  31. Hervé F, Urien S, Albengres E, Duché J-C, Tillement J-P (1994) Drug binding in plasma: A summary of recent trends in the study of drug and hormone binding. Clin Pharmacokinet 26:44–58PubMedCrossRefGoogle Scholar
  32. Höer A, Oberdisse E (1990) Das Phosphoinositid-Phospholipase-C-System, ein verzweigter Weg der transmembranären Signalübertragung. Med Monatsschr Pharm 13:243–252PubMedGoogle Scholar
  33. Hoyer D, Boddeke HWGM (1993) Partial agonists, full agonists, antagonists: Dilemmas of definition. Trends Pharmacol Sci 14:270–275PubMedCrossRefGoogle Scholar
  34. Jenkinson DH (1991) How we describe competitive antagonists: Three questions of usage. Trends Pharmacol Sci 12:53–54PubMedCrossRefGoogle Scholar
  35. Johnston D, Williams S, Jaffe D, Gray R (1992) NMDA-receptor-independent long-term potentiation. Annu Rev Physiol 54:489–505PubMedCrossRefGoogle Scholar
  36. Katz M, Poulsen BJ (1971) Absorption of drugs through the skin. In: Brodie BB, Gilette JR (Hrsg) Handbuch der experimentellen Pharmakologie, Bd XXVIII/1: Concepts in biochemical pharmacology. Springer, Berlin Heidelberg New York, S 103–174Google Scholar
  37. Kauffman FC (ed) (1994) Conjugation-deconjugation reactions in drug metabolism and toxicity, In: Handbook of Experimental Pharmacology, vol 112. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  38. Kemp JA, Leeson PD (1993) The glycine site of the NMDA receptor — five years on. Trends Pharmacol Sci 14:20–25PubMedCrossRefGoogle Scholar
  39. Krstic RV (1976) Die Ultrastruktur der Säugetierzelle. Springer, Berlin Heidelberg New YorkGoogle Scholar
  40. Landers JP, Bunce NJ (1991) The Ah receptor and the mechanism of dioxin toxicity. Biochem J 276:273–287PubMedGoogle Scholar
  41. Leff P (1995) The two-state model of receptor activation. Trends Pharmacol Sci 16:89–97PubMedCrossRefGoogle Scholar
  42. Lefkovitz RJ (1993) G protein-coupled receptor kinases. Cell 74:409–412CrossRefGoogle Scholar
  43. Levitan IB (1994) Modulation of ion channels by protein phosphorylation and dephosphorylation. Annu Rev Physiol 56:193–212PubMedCrossRefGoogle Scholar
  44. Levitan IB, Kaczmarek LK (1991) The neuron: Cell and molecular biology. Oxford Univ Press, New York OxfordGoogle Scholar
  45. Lincoln TM, Cornwell TL (1993) Intracellular cyclic GMP receptor proteins. FASEB J 7:328–338PubMedGoogle Scholar
  46. MacDonald RL, Olsen RW (1994) GABAA receptor channels. Annu Rev Neurosci 17:569–602PubMedCrossRefGoogle Scholar
  47. Mangelsdorf DJ, Thummel C, Beato M et al. (1995) The nuclear receptor superfamily: The second decade. Cell 83:835–839PubMedCrossRefGoogle Scholar
  48. Meissner G (1994) Ryanodine receptor/Ca2+ release channels and their regulation by endogenous effectors. Annu Rev Physiol 56:485–508PubMedCrossRefGoogle Scholar
  49. Milligan G (1993) Agonist regulation of cellular G protein levels and distribution: Mechanisms and functional implications. Trends Pharmacol Sci 14:413–418PubMedCrossRefGoogle Scholar
  50. Miners JO, Mackenzie PI (1991) Drug glucuronidation in humans. Pharmacol Ther 51:347–369PubMedCrossRefGoogle Scholar
  51. Morgan DJ, Bray KM (1994) Lean body mass as a predictor of drug dosage: Implications for drug therapy. Clin Pharmacokinet 26:292–307PubMedCrossRefGoogle Scholar
  52. Murray M (1992) P 450 enzymes: Inhibition mechanisms, genetic regulation and effects of liver disease. Clin Pharmacokinet 23:132–146PubMedCrossRefGoogle Scholar
  53. Nahorski SR (ed) (1990) Transmembrane signalling, intracellular messengers and implications for drug development. Wiley, New YorkGoogle Scholar
  54. Nakamura S, Nishizuka Y (1994) Lipid mediators and protein kinase C activation for the intracellular signaling network. J Biochem 115:1029–1034PubMedGoogle Scholar
  55. Petersen OH, Petersen CCH, Kasai H (1994) Calcium and hormone action. Annu Rev Physiol 56:297–319PubMedCrossRefGoogle Scholar
  56. Pöch G, Juan H (1990) Wirkungen von Pharmaka, 2. Aufl. Thieme, Stuttgart New YorkGoogle Scholar
  57. Pouysségur J, Seuwen K (1992) Transmembrane receptors and intracellular pathways that control cell proliferation. Annu Rev Physiol 54:195–210PubMedCrossRefGoogle Scholar
  58. Pratt WB, Taylor P (eds) (1990) Principles of drug action: The basis of pharmacology, 3rd edn. Churchill Livingstone, New York Edinburgh London Melbourne TokyoGoogle Scholar
  59. Ribeiro RCJ, Kushner PJ, Baxter JD (1995) The nuclear hormone receptor gene family. Annu Rev Med 46:443–453PubMedCrossRefGoogle Scholar
  60. Roitt IM, Brostoff J, Male DK (1991) Kurzes Lehrbuch der Immunologie, 2. Aufl. Thieme, Stuttgart New YorkGoogle Scholar
  61. Schanker LS et al. (1957) Absorption of drugs from the stomach, I. The rat. J Pharmacol Exp Ther 120:528–539PubMedGoogle Scholar
  62. Scheler W (1989) Grundlagen der allgemeinen Pharmakologie. Fischer, JenaGoogle Scholar
  63. Schmid SL (1992) The mechanism of receptor-mediated endocytosis: More questions than answers. Bioessays 14:589–596PubMedCrossRefGoogle Scholar
  64. Sheiner LB, Ludden TM (1992) Population pharmacokinetics/ dynamics. Annu Rev Pharmacol Toxicol 32:185–209PubMedCrossRefGoogle Scholar
  65. Singh P, Maibach HI (1994) Transdermal iontophoresis: Pharmacokinetic considerations. Clin Pharmacokinet 26:327–334PubMedCrossRefGoogle Scholar
  66. Sorentino V, Volpe P (1993) Ryanodine receptors: how many, where and why? Trends Pharmacol Sci 14:98–103CrossRefGoogle Scholar
  67. Tanaka C, Nishizuka Y (1994) The protein kinase C family for neuronal signalling. Annu Rev Neurosci 17:551–567PubMedCrossRefGoogle Scholar
  68. Tephly TR, Burchell B (1990) UDP-glucuronosyltransferases: A family of detoxifying enzymes. Trends Pharmacol Sci 11:276–279PubMedCrossRefGoogle Scholar
  69. Thomas SHL (1993) Paracetamol (acetaminophen) poisoning. Pharmacol Ther 69:91–120CrossRefGoogle Scholar
  70. Walton KM, Dixon JE (1993) Protein tyrosine phosphatases. Annu Rev Biochem 62:101–120PubMedCrossRefGoogle Scholar
  71. Waxman DJ, Azaroff L (1992) Phenobarbital induction of cytochrome P-450 gene expression. Biochem J 281:577–592PubMedGoogle Scholar
  72. Weinstein H, Mehler EL (1994) Ca2+-binding and structural dynamics in the functions of calmodulin. Annu Rev Physiol 56:213–236PubMedCrossRefGoogle Scholar
  73. Welling PG, Balant LP (eds) (1994) Pharmacokinetis of drugs, In: Handbook of Experimental Pharmacology, vol 110. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  74. Wickman K, Clapham DE (1995) Ion channel regulation by G proteins. Physiol Rev 75:865–885PubMedGoogle Scholar
  75. Williams AC, Barry BW (1992) Skin absorption enhancers. Crit Rev Ther Drug Carrier Syst 9:305–353PubMedGoogle Scholar
  76. Wojcikiewicz RJH, Tobin AB, Nahorski SR (1993) Desensitization of cell signalling mediated by phosphoinositidase C. Trends Pharmacol Sci 14:279–285PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • E. Oberdisse

There are no affiliations available

Personalised recommendations